Accord Healthcare Limited (additional secondary packaging)

Ukraine

All drugs from this manufacturer

  • FLUDARABINE ACCORD

    The drug is intended for the treatment of B-cell chronic lymphocytic leukemia in adult patients with adequate bone marrow reserve.

    Dosage form: solution for injection, concentrate

    Active substance Dosage
    fludarabine 25 mg/ml

    ATC: L01BB05

  • VINORELBINE ACCORD

    The drug is indicated for adults for the treatment of non-small cell lung cancer (stage III or IV), as well as for advanced stage III or IV breast cancer that has recurred after ineffective anthracycline chemotherapy.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    vinorelbine 10 mg/ml

    ATC: L01CA04